Blogs

The complete 8-factor pharma sector analysis framework for Indian value investors. Learn how to separate quality pharma multibaggers from regulatory time bombs using business model classification, regulatory risk profiling, revenue quality, R&D productivity, margin structure, balance sheet strength, capital allocation, and model-specific valuation.

Sensex jumped 577 points and Nifty reclaimed 23,961 as banking heavyweights led the rebound. But the real lesson today is not about indices — it is about concentration, conviction, and quality. Plus: Titan Biotech compounds silently at 94% YoY profit growth.

How Page Industries — the exclusive Jockey licensee in India — turned ₹1 lakh into ₹94 lakh over 19 years, and the five timeless value investing lessons every Indian investor must internalise.

Every year, thousands of Indian retail investors lose money not from bad markets — but from companies where insiders quietly siphon value through Related Party Transactions […]